Ranbaxy To Develop Drug For Malaria Foundation
Ranbaxy Laboratories Ltd has replaced Roche, the Swiss drugs major, as the pharmaceutical partner to the prestigious Medicines for Malaria Venture, Geneva, for the development of a synthetic peroxide anti-malarial drug. Roche had partnered the venture